Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

Aiforia Technologies Oyj: Aiforia and Orion collaborate to develop AI solutions for image analytics in drug research

Aiforia Technologies

Aiforia Technologies Plc, Press Release, 05 July 2023 at 12:00 a.m. EEST. Aiforia and Finnish pharmaceutical company Orion have agreed to collaborate on developing AI-based image analysis solutions for preclinical research and product development.

Through this collaboration, Aiforia will gain valuable insight from Orion into the needs of its preclinical customer base and will be better able to address these needs with its product portfolio.

In spring 2023, Orion launched a Business Finland-funded project (https://www.orion.fi/en/newsroom/newsroom-listing/releases/press-releases/2023/orion-is-building-a-unique-pharmaceutical-research-ecosystem-in-finland--using-data-and-artificial-intelligence-to-shorten-the-development-time-of-new-innovative-medicines/) that aims to shorten the development time of new innovative medicines by using data and artificial intelligence. The partnership with Orion supports Aiforia's strategy to rapidly bring internationally unique AI solutions to the market that can enhance both preclinical research and clinical diagnostics.

Further inquiries

Jukka Tapaninen, CEO, Aiforia Technologies Plc

tel. +33 61 041 6686

https://investors.aiforia.com/

Certified Adviser

UB Securities Ltd

tel. +358 9 25 380 225 

About Aiforia

Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep-learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud-based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis beyond current capabilities across various fields, from oncology to neuroscience and more. Find out more atwww.aiforia.com

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team